We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance on Combination Knee Products Stresses Primary Endpoints
Guidance on Combination Knee Products Stresses Primary Endpoints
January 20, 2012
Primary endpoints for Phase III clinical trials of combination products used to repair knee cartilage should be either improvement in physical function or reduction of pain, according to an FDA final guidance.